Sun Pharma forays into health tech with investments in Agatsa Software and Remedio

According to a regulatory filing, Sun Pharma has acquired 26.09 per cent stake in Agatsa Software to boost digital diagnostics.

Read Also

Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues

It has also bagged a 27.39 per cent stake in Remedio Innovative Solutions, for eye disease detection.